Sznurkowski JJ, Rys J, Kowalik A, Zolciak-Siwinska A, Bodnar L, Chudecka-Glaz A, et al. The Polish society of gynecological oncology tips for the prognosis and therapy of endometrial carcinoma. J Clin Med. 2023;12(4):1480.
St Laurent J, Liu JF. Therapy approaches for platinum-resistant ovarian most cancers. J Clin Oncol. 2024;42(2):127–33.
Bogani G, Monk BJ, Powell MA, Westin SN, Slomovitz B, Moore KN, et al. Including immunotherapy to first-line therapy of superior and metastatic endometrial most cancers. Ann Oncol. 2024;35(5):414–28.
Godbole N, Quinn A, Carrion F, Pelosi E, Salomon C. Extracellular vesicles as a possible supply platform for CRISPR-Cas primarily based remedy in epithelial ovarian most cancers. Semin Most cancers Biol. 2023;96:64–81.
Penny SM. Ovarian most cancers: an outline. Radiol Technol. 2020;91(6):561–75.
Mitra A, Gultekin M, Burney Ellis L, Bizzarri N, Bowden S, Taumberger N, et al. Genital tract microbiota composition profiles and use of prebiotics and probiotics in gynaecological most cancers prevention: evaluation of the present proof, the European Society of Gynaecological Oncology prevention committee assertion. Lancet Microbe. 2024;5(3):e291–300.
Wang Y, Duval AJ, Adli M, Matei D. Biology-driven remedy advances in high-grade serous ovarian most cancers. J Clin Make investments. 2024;134(1): e174013.
Garg V, Oza AM. Therapy of ovarian most cancers past PARP inhibition: present and future choices. Medication. 2023;83(15):1365–85.
Crosbie EJ, Kitson SJ, McAlpine JN, Mukhopadhyay A, Powell ME, Singh N. Endometrial most cancers. Lancet. 2022;399(10333):1412–28.
Gavinski Ok, DiNardo D. Cervical most cancers screening. Med Clin North Am. 2023;107(2):259–69.
Dey DK, Krause D, Rai R, Choudhary S, Dockery LE, Chandra V. The function and participation of immune cells within the endometrial tumor microenvironment. Pharmacol Ther. 2023;251: 108526.
Perelli F, Mattei A, Scambia G, Cavaliere AF. Editorial: Strategies in gynecological oncology. Entrance Oncol. 2023;13:1167088.
Virarkar M, Bhosale PR. Editorial: ladies in gynecological oncology 2021. Entrance Oncol. 2023;13:1220467.
Baldewpersad Tewarie N, van Driel WJ, van Ham M, Wouters MW, Rome RM, Høgdall CK, et al. An summary of scientific high quality registries (CQRs) on gynecological oncology worldwide. Eur J Surg Oncol. 2022;48(10):2094–103.
Corrò C, Novellasdemunt L, Li VSW. A quick historical past of organoids. Am J Physiol Cell Physiol. 2020;319(1):C151-c165.
Zhao Z, Chen X, Dowbaj AM, Sljukic A, Bratlie Ok, Lin L, et al. Organoids. Nat Rev Strategies Primers. 2022;2:94.
Li W, Liu Y, Hou Q, Huang W, Zheng H, Gao X, et al. Lactobacillus plantarum improves the effectivity of sheep manure composting and the standard of the ultimate product. Bioresour Technol. 2020;297: 122456.
Fenner A. Genomic profiling suggests doable immunotherapy response in uncommon subtypes. Nat Rev Urol. 2020;17(3):132.
Izzo R, Bevivino G, De Simone V, Sedda S, Monteleone I, Marafini I, et al. Knockdown of Smad7 with a selected antisense oligonucleotide attenuates colitis and colitis-driven colonic fibrosis in mice. Inflamm Bowel Dis. 2018;24(6):1213–24.
Naureen Z, Lorusso L, Manganotti P, Caruso P, Mazzon G, Cecchin S, et al. Genetics of ache: From uncommon Mendelian problems to genetic predisposition to ache. Acta Biomed. 2020;91(13-S): e2020010.
Flores-Johnson EA, Firm-Rodriguez BA, Koh-Dzul JF, Carrillo JG. Shaking desk check of U-shaped partitions product of fiber-reinforced foamed concrete. Supplies (Basel, Switzerland). 2020;13(11):2534.
LeSavage BL, Suhar RA, Broguiere N, Lutolf MP, Heilshorn SC. Subsequent-generation most cancers organoids. Nat Mater. 2022;21(2):143–59.
Yang S, Hu H, Kung H, Zou R, Dai Y, Hu Y, et al. Organoids: the present standing and biomedical functions. Med Comm. 2023;4(3):e274.
Chumduri C, Turco MY. Organoids of the feminine reproductive tract. J Mol Med (Berl). 2021;99(4):531–53.
Marinić M, Rana S, Lynch VJ. Derivation of endometrial gland organoids from time period placenta. Placenta. 2020;101:75–9.
Li X, Zheng M, Xu B, Li D, Shen Y, Nie Y, et al. Technology of offspring-producing 3D ovarian organoids derived from feminine germline stem cells and their software in toxicological detection. Biomaterials. 2021;279: 121213.
Boretto M, Cox B, Noben M, Hendriks N, Fassbender A, Roose H, et al. Improvement of organoids from mouse and human endometrium displaying endometrial epithelium physiology and long-term expandability. Improvement. 2017;144(10):1775–86.
Tang S, Parks SE, Liao Z, Cope DI, Blutt SE, Monsivais D. Establishing 3D endometrial organoids from the mouse uterus. J Vis Exp. 2023;191:10.
Boretto M, Maenhoudt N, Luo X, Hennes A, Boeckx B, Bui B, et al. Affected person-derived organoids from endometrial illness seize scientific heterogeneity and are amenable to drug screening. Nat Cell Biol. 2019;21(8):1041–51.
Haider S, Gamperl M, Burkard TR, Kunihs V, Kaindl U, Junttila S, et al. Estrogen signaling drives ciliogenesis in human endometrial organoids. Endocrinology. 2019;160(10):2282–97.
Fitzgerald HC, Kelleher AM, Ranjit C, Schust DJ, Spencer TE. Basolateral secretions of human endometrial epithelial organoids affect stromal cell decidualization. Mol Hum Reprod. 2023;29(4):gaad007.
Dong Y, Li J, Cao D, Zhong J, Liu X, Duan YG, et al. Built-in microRNA and secretome evaluation of human endometrial organoids reveal the miR-3194-5p/aquaporin/S100A9 module in regulating trophoblast features. Mol Cell Proteom. 2023;22(4): 100526.
Filby CE, Wyatt KA, Mortlock S, Cousins FL, McKinnon B, Tyson KE, et al. Comparability of organoids from menstrual fluid and hormone-treated endometrium: novel instruments for gynecological analysis. J Pers Med. 2021;11(12):1314.
Fitzgerald HC, Dhakal P, Behura SK, Schust DJ, Spencer TE. Self-renewing endometrial epithelial organoids of the human uterus. Proc Natl Acad Sci USA. 2019;116(46):23132–42.
Zhang Y, Chen W, Dong X, Shang W, Shao S, Zhang L. Lengthy-term upkeep of human endometrial epithelial organoids and their stem cell properties. Reprod Toxicol. 2024;123: 108522.
Hewitt SC, Wu SP, Wang T, Younger SL, Spencer TE, DeMayo FJ. Progesterone signaling in endometrial epithelial organoids. Cells. 2022;11(11):1760.
Cochrane DR, Campbell KR, Greening Ok, Ho GC, Hopkins J, Bui M, et al. Single cell transcriptomes of regular endometrial derived organoids uncover novel cell sort markers and cryptic differentiation of major tumours. J Pathol. 2020;252(2):201–14.
Hewitt SC, Wu SP, Wang T, Ray M, Brolinson M, Younger SL, et al. The estrogen receptor α Cistrome in human endometrium and epithelial organoids. Endocrinology. 2022;163(9):bqac116.
Geurts MH, Gandhi S, Boretto MG, Akkerman N, Derks LLM, van Son G, et al. One-step technology of tumor fashions by base editor multiplexing in grownup stem cell-derived organoids. Nat Commun. 2023;14(1):4998.
Maru Y, Tanaka N, Tatsumi Y, Nakamura Y, Itami M, Hippo Y. Kras activation in endometrial organoids drives mobile transformation and epithelial-mesenchymal transition. Oncogenesis. 2021;10(6):46.
Maru Y, Tanaka N, Tatsumi Y, Nakamura Y, Yao R, Noda T, et al. Probing the tumorigenic potential of genetic interactions reconstituted in murine fallopian tube organoids. J Pathol. 2021;255(2):177–89.
Lõhmussaar Ok, Kopper O, Korving J, Begthel H, Vreuls CPH, van Es JH, et al. Assessing the origin of high-grade serous ovarian most cancers utilizing CRISPR-modification of mouse organoids. Nat Commun. 2020;11(1):2660.
Bui BN, Boretto M, Kobayashi H, van Hoesel M, Steba GS, van Hoogenhuijze N, et al. Organoids might be established reliably from cryopreserved biopsy catheter-derived endometrial tissue of infertile ladies. Reprod Biomed On-line. 2020;41(3):465–73.
Wiwatpanit T, Murphy AR, Lu Z, Urbanek M, Burdette JE, Woodruff TK, et al. Scaffold-free endometrial organoids reply to extra androgens related to polycystic ovarian syndrome. J Clin Endocrinol Metab. 2020;105(3):769–80.
Xu C, Alameri A, Leong W, Johnson E, Chen Z, Xu B, et al. Multiscale engineering of mind organoids for illness modeling. Adv Drug Deliv Rev. 2024;210: 115344.
Han X, Cai C, Deng W, Shi Y, Li L, Wang C, et al. Panorama of human organoids: Supreme mannequin in clinics and analysis. Innovation (Camb). 2024;5(3): 100620.
Park S, Cho SW. Bioengineering toolkits for potentiating organoid therapeutics. Adv Drug Deliv Rev. 2024;208: 115238.
Maharjan S, Ma C, Singh B, Kang H, Orive G, Yao J, et al. Superior 3D imaging and organoid bioprinting for biomedical analysis and therapeutic functions. Adv Drug Deliv Rev. 2024;208: 115237.
Wang H, Ning X, Zhao F, Zhao H, Li D. Human organoids-on-chips for biomedical analysis and functions. Theranostics. 2024;14(2):788–818.
Roberto de Barros N, Wang C, Maity S, Peirsman A, Nasiri R, Herland A, et al. Engineered organoids for biomedical functions. Adv Drug Deliv Rev. 2023;203:115142.
Barroso M, Monaghan MG, Niesner R, Dmitriev RI. Probing organoid metabolism utilizing fluorescence lifetime imaging microscopy (FLIM): the following frontier of drug discovery and illness understanding. Adv Drug Deliv Rev. 2023;201: 115081.
Landon-Brace N, Li NT, McGuigan AP. Exploring new dimensions of tumor heterogeneity: the appliance of single cell evaluation to organoid-based 3D in vitro fashions. Adv Healthc Mater. 2023;12(26): e2300903.
Zhang Y, Li G, Wang J, Zhou F, Ren X, Su J. Small joint organoids 3D bioprinting: building technique and software. Small. 2024;20(8): e2302506.
Kutluk H, Bastounis EE, Constantinou I. Integration of extracellular matrices into organ-on-chip techniques. Adv Healthc Mater. 2023;12(20): e2203256.
Chien Y, Hsiao YJ, Chou SJ, Lin TY, Yarmishyn AA, Lai WY, et al. Nanoparticles-mediated CRISPR-Cas9 gene remedy in inherited retinal ailments: functions, challenges, and rising alternatives. J Nanobiotechnology. 2022;20(1):511.
Lin SC, Haga Ok, Zeng XL, Estes MK. Technology of CRISPR-Cas9-mediated genetic knockout human intestinal tissue-derived enteroid strains by lentivirus transduction and single-cell cloning. Nat Protoc. 2022;17(4):1004–27.
Qu J, Kalyani FS, Liu L, Cheng T, Chen L. Tumor organoids: synergistic functions, present challenges, and future prospects in most cancers remedy. Most cancers Commun (Lond). 2021;41(12):1331–53.
Xu Y, Cai S, Wang Q, Cheng M, Hui X, Dzakah EE, et al. Multi-lineage human endometrial organoids on acellular amniotic membrane for endometrium regeneration. Cell Transplant. 2023;32:9636897231218408.
Hennes A, Held Ok, Boretto M, De Clercq Ok, Van den Eynde C, Vanhie A, et al. Useful expression of the mechanosensitive PIEZO1 channel in major endometrial epithelial cells and endometrial organoids. Sci Rep. 2019;9(1):1779.
Lõhmussaar Ok, Oka R, Espejo Valle-Inclan J, Smits MHH, Wardak H, Korving J, et al. Affected person-derived organoids mannequin cervical tissue dynamics and viral oncogenesis in cervical most cancers. Cell Stem Cell. 2021;28(8):1380-1396.e1386.
Wu YL, Li JQ, Sulaiman Z, Liu Q, Wang CY, Liu SP, et al. Optimization of endometrial most cancers organoids institution by cancer-associated fibroblasts. Neoplasma. 2022;69(4):877–85.
Katcher A, Yueh B, Ozler Ok, Nizam A, Kredentser A, Chung C, et al. Establishing patient-derived organoids from human endometrial most cancers and regular endometrium. Entrance Endocrinol (Lausanne). 2023;14:1059228.
Huang H, Pan Y, Huang J, Zhang C, Liao Y, Du Q, et al. Affected person-derived organoids as personalised avatars and a possible immunotherapy mannequin in cervical most cancers. iScience. 2023;26(11):108198.
Senkowski W, Gall-Mas L, Falco MM, Li Y, Lavikka Ok, Kriegbaum MC, et al. A platform for environment friendly institution and drug-response profiling of high-grade serous ovarian most cancers organoids. Dev Cell. 2023;58(12):1106-1121.e1107.
Thorel L, Morice PM, Paysant H, Florent R, Babin G, Thomine C, et al. Comparative evaluation of response to therapies and molecular options of tumor-derived organoids versus cell strains and PDX derived from the identical ovarian clear cell carcinoma. J Exp Clin Most cancers Res. 2023;42(1):260.
Maru Y, Tanaka N, Itami M, Hippo Y. Environment friendly use of patient-derived organoids as a preclinical mannequin for gynecologic tumors. Gynecol Oncol. 2019;154(1):189–98.
Chen YA, Lu CY, Cheng WF, Kuo KT, Yu CW, Ho HN, et al. An experimental mannequin for ovarian most cancers: propagation of ovarian most cancers initiating cells and technology of ovarian most cancers organoids. BMC Most cancers. 2022;22(1):967.
Graham O, Rodriguez J, van Biljon L, Fashemi B, Graham E, Fuh Ok, et al. Technology and culturing of high-grade serous ovarian most cancers patient-derived organoids. J Vis Exp. 2023;191:10.
Hoffmann Ok, Berger H, Kulbe H, Thillainadarasan S, Mollenkopf HJ, Zemojtel T, et al. Steady growth of high-grade serous ovarian most cancers organoids requires a low-Wnt surroundings. Embo j. 2020;39(6): e104013.
Vias M, Morrill Gavarró L, Sauer CM, Sanders DA, Piskorz AM, Couturier DL, et al. Excessive-grade serous ovarian carcinoma organoids as fashions of chromosomal instability. Elife. 2023;12: e83867.
Chen X, Liu X, Li QH, Lu BF, Xie BM, Ji YM, et al. A patient-derived organoid-based examine recognized an ASO focusing on SNORD14E for endometrial most cancers by way of lowering aberrant FOXM1 expression and β-catenin nuclear accumulation. J Exp Clin Most cancers Res. 2023;42(1):230.
Wang Z, Chen W, Zuo L, Xu M, Wu Y, Huang J, et al. The Fibrillin-1/VEGFR2/STAT2 signaling axis promotes chemoresistance through modulating glycolysis and angiogenesis in ovarian most cancers organoids and cells. Most cancers Commun (Lond). 2022;42(3):245–65.
Solar H, Wang H, Wang X, Aoki Y, Wang X, Yang Y, et al. Aurora-A/SOX8/FOXK1 signaling axis promotes chemoresistance through suppression of cell senescence and induction of glucose metabolism in ovarian most cancers organoids and cells. Theranostics. 2020;10(15):6928–45.
Hoarau-Véchot J, Blot-Dupin M, Pauly L, Touboul C, Rafii S, Rafii A, et al. Akt-activated endothelium will increase most cancers cell proliferation and resistance to therapy in ovarian most cancers cell organoids. Int J Mol Sci. 2022;23(22):14173.
Dai Y, Xu J, Gong X, Wei J, Gao Y, Chai R, et al. Human fallopian tube-derived organoids with TP53 and RAD51D mutations recapitulate an early stage high-grade serous ovarian most cancers phenotype in vitro. Int J Mol Sci. 2024;25(2):886.
Wang H, Zhang Y, Miao H, Xu T, Nie X, Cheng W. CircRAD23B promotes proliferation and carboplatin resistance in ovarian most cancers cell strains and organoids. Most cancers Cell Int. 2024;24(1):42.
Vernon M, Lambert B, Meryet-Figuière M, Brotin E, Weiswald LB, Paysant H, et al. Useful miRNA screening identifies wide-ranging antitumor properties of miR-3622b-5p and divulges a brand new therapeutic mixture technique in ovarian tumor organoids. Mol Most cancers Ther. 2020;19(7):1506–19.
Cai X, Li Y, Zheng J, Liu L, Jiao Z, Lin J, et al. Modeling of senescence-related chemoresistance in ovarian most cancers utilizing knowledge evaluation and patient-derived organoids. Entrance Oncol. 2023;13:1291559.
Wan Y, Zhang Y, Meng H, Miao H, Jiang Y, Zhang L, et al. Bractoppin, a BRCA1 carboxy-terminal area (BRCT) inhibitor, suppresses tumor development in ovarian borderline tumor organoids. Biochem Biophys Res Commun. 2023;638:76–83.
Dahl MJ, Lofgren KA, Haugen C, Harmon GE, Hughes SP, Cowden Dahl KD. Gemcitabine mixture therapies induce apoptosis in uterine carcinosarcoma patient-derived organoids. Entrance Oncol. 2024;14:1368592.
Maru Y, Kohno M, Suzuka Ok, Odaka A, Masuda M, Araki A, et al. Institution and characterization of a number of patient-derived organoids from a case of superior endometrial most cancers. Hum Cell. 2024;37(3):840–53.
Maru Y, Tanaka N, Ebisawa Ok, Odaka A, Sugiyama T, Itami M, et al. Institution and characterization of patient-derived organoids from a younger affected person with cervical clear cell carcinoma. Most cancers Sci. 2019;110(9):2992–3005.
Seol HS, Oh JH, Choi E, Kim S, Kim H, Nam EJ. Preclinical investigation of patient-derived cervical most cancers organoids for precision drugs. J Gynecol Oncol. 2023;34(3): e35.
Di Fonte R, Strippoli S, Garofoli M, Cormio G, Serratì S, Loizzi V, et al. Cervical most cancers advantages from trabectedin mixture with the β-blocker propranolol: in vitro and ex vivo evaluations in patient-derived organoids. Entrance Cell Dev Biol. 2023;11:1178316.
Chen J, Zhao L, Peng H, Dai S, Quan Y, Wang M, et al. An organoid-based drug screening recognized a menin-MLL inhibitor for endometrial most cancers by way of regulating the HIF pathway. Most cancers Gene Ther. 2021;28(1–2):112–25.
Sengal AT, Bonazzi V, Smith D, Moiola CP, Lourie R, Rogers R, et al. Endometrial most cancers PDX-derived organoids (PDXOs) and PDXs with FGFR2c isoform expression are delicate to FGFR inhibition. NPJ Summary Oncol. 2023;7(1):127.
Girda E, Huang EC, Leiserowitz GS, Smith LH. The usage of endometrial most cancers patient-derived organoid tradition for drug sensitivity testing is possible. Int J Gynecol Most cancers. 2017;27(8):1701–7.
Zhang HH, Li AH. Lengthy non-coding RNA FEZF1-AS1 is up-regulated and related to poor prognosis in sufferers with cervical most cancers. Eur Rev Med Pharmacol Sci. 2018;22(11):3357–62.
Bi J, Thiel KW, Litman JM, Zhang Y, Devor EJ, Newtson AM, et al. Characterization of a TP53 somatic variant of unknown perform from an ovarian most cancers affected person utilizing organoid tradition and computational modeling. Clin Obstet Gynecol. 2020;63(1):109–19.
Maenhoudt N, Defraye C, Boretto M, Jan Z, Heremans R, Boeckx B, et al. Growing organoids from ovarian most cancers as experimental and preclinical fashions. Stem Cell Rep. 2020;14(4):717–29.
Chen H, Gotimer Ok, De Souza C, Tepper CG, Karnezis AN, Leiserowitz GS, et al. Quick-term organoid tradition for drug sensitivity testing of high-grade serous carcinoma. Gynecol Oncol. 2020;157(3):783–92.
Cao Q, Li L, Zhao Y, Wang C, Shi Y, Tao X, et al. PARPi decreased major ovarian most cancers organoid progress by way of early apoptosis and base excision restore pathway. Cell Transplant. 2023;32:9636897231187996.
Keles H, Schofield CA, Rannikmae H, Edwards EE, Mohamet L. A scalable 3D high-content imaging protocol for measuring a drug induced DNA harm response utilizing immunofluorescent subnuclear γH2AX spots in affected person derived ovarian most cancers organoids. ACS Pharmacol Transl Sci. 2023;6(1):12–21.
de Witte CJ, Espejo Valle-Inclan J, Hami N, Lõhmussaar Ok, Kopper O, Vreuls CPH, et al. Affected person-derived ovarian most cancers organoids mimic scientific response and exhibit heterogeneous inter- and intrapatient drug responses. Cell Rep. 2020;31(11): 107762.
Nanki Y, Chiyoda T, Hirasawa A, Ookubo A, Itoh M, Ueno M, et al. Affected person-derived ovarian most cancers organoids seize the genomic profiles of major tumours relevant for drug sensitivity and resistance testing. Sci Rep. 2020;10(1):12581.
Gorski JW, Zhang Z, McCorkle JR, DeJohn JM, Wang C, Miller RW, et al. Using patient-derived epithelial ovarian most cancers tumor organoids to foretell carboplatin resistance. Biomedicines. 2021;9(8):1021.
Cavarzerani E, Caligiuri I, Bartoletti M, Canzonieri V, Rizzolio F. 3D dynamic cultures of HGSOC organoids to mannequin progressive and customary therapies. Entrance Bioeng Biotechnol. 2023;11:1135374.
Grey HJ, Chatterjee P, Rosati R, Appleyard LR, Durenberger GJ, Diaz RL, et al. Extraordinary scientific response to ibrutinib in low-grade ovarian most cancers guided by organoid drug testing. NPJ Summary Oncol. 2023;7(1):45.
Chen W, Fang PH, Zheng B, Liang Y, Mao Y, Jiang X, et al. Efficient therapy for recurrent ovarian most cancers guided by drug sensitivity from ascites-derived organoid: a case report. Int J Womens Well being. 2023;15:1047–57.
Al-Aloosi M, Prechtl AM, Chatterjee P, Bernard B, Kemp CJ, Rosati R, et al. Case report: ex vivo tumor organoid drug testing identifies therapeutic choices for stage IV ovarian carcinoma. Entrance Oncol. 2023;13:1267650.
Cesari E, Ciucci A, Pieraccioli M, Caggiano C, Nero C, Bonvissuto D, et al. Twin inhibition of CDK12 and CDK13 uncovers actionable vulnerabilities in patient-derived ovarian most cancers organoids. J Exp Clin Most cancers Res. 2023;42(1):126.
Symons M, Feeney GFX, Gallagher MR, Younger RM, Connor JP. Machine studying vs dependancy therapists: a pilot examine predicting alcohol dependence therapy consequence from affected person knowledge in habits remedy with adjunctive remedy. J Subst Abuse Deal with. 2019;99:156–62.
Mani VR, Kalabin A, Nwakanama C, Suman P, Ahmed L. Preoperative versus intraoperative prognosis of hiatal hernia in bariatric inhabitants. Surg Obes Relat Dis. 2019;15(11):1949–55.
Younger MF, Ramakrishnan U. Maternal undernutrition earlier than and through being pregnant and offspring well being and improvement. Ann Nutr Metab. 2021. https://doi.org/10.1159/000510595.
Lu Ok, Li B, Zhang H, Xu Z, Music D, Gao L, et al. A novel silicone spinoff of pure osalmid (DCZ0858) induces apoptosis and cell cycle arrest in diffuse massive B-cell lymphoma through the JAK2/STAT3 pathway. Sign Transduct Goal Ther. 2020;5(1):31.
Li FC, Kishen A. 3D organoids for regenerative endodontics. Biomolecules. 2023;13(6):900.
Ichida JK, Ko CP. Organoids develop motor expertise: 3D human neuromuscular junctions. Cell Stem Cell. 2020;26(2):131–3.
Dao V, Yuki Ok, Lo YH, Nakano M, Kuo CJ. Immune organoids: from tumor modeling to precision oncology. Tendencies Most cancers. 2022;8(10):870–80.
Robertson IM, Klein BA, Sykes BD. Optimizing fluorine labelling for (19)F solid-state NMR in oriented organic techniques. J Biomol NMR. 2020;74(1):1–7.
Yu D, Wu X, Li X, Liu X, Jiang Ok, Zhao Q, et al. Improvement and exterior validation of secure discharge standards after radical gastrectomy. Most cancers Manag Res. 2021;13:5251–61.
Chang PF, Bazarova NN, Wethington E. How older adults with persistent ache handle social assist interactions with cellular media. Well being Commun. 2022;37(3):384–96.
Raba AA, O’Sullivan A, Miletin J. Prediction of the necessity for phototherapy throughout hospital keep in preterm infants by transcutaneous bilirubinometry. Early Human Dev. 2020;146: 105029.
Scheil-Bertram S, Wardelmann E. Report of the bone, joint, and gentle tissue pathology working group : DGP convention on 4 june 2020. Der Pathol. 2020;41(2):178–80.
Falk AE, Stiles Ok, Krein IN, Lee SS. Parenting habits and progress of kid conduct issues: moderation by callous-unemotional traits. Aggress Behav. 2021;47(3):251–9.
Greaux KM, de Vries NK, Bessems Ok, Harting J, van Assema P. Does partnership variety in intersectoral policymaking matter for well being selling intervention packages’ composition? A multiple-case examine within the Netherlands. Well being Promot Int. 2021;36(3):616–29.
Nyhus MO, Mathew S, Salvesen O, Salvesen KA, Stafne S, Volloyhaug I. Impact of preoperative pelvic flooring muscle coaching on pelvic flooring muscle contraction and symptomatic and anatomical pelvic organ prolapse after surgical procedure: randomized managed trial. Ultrasound Obstet Gynecol. 2020;56(1):28–36.
Rossi C, Lees M, Mehta V, Heikura T, Martin J, Zachary I, et al. Comparability of effectivity and performance of vascular endothelial progress issue adenovirus vectors in endothelial cells for gene remedy of placental insufficiency. Hum Gene Ther. 2020;31(21–22):1190–202.
Zhang J, Deng G, Qiao L, Luo H, Liu Q, Liang N, et al. Impact of galectin-3 on vasculogenic mimicry in esophageal most cancers cells. Oncol Lett. 2019;17(1):719.
Gilet JG, Ivanova EL, Trofimova D, Rudolf G, Meziane H, Broix L, et al. Conditional switching of KIF2A mutation supplies new insights into cortical malformation pathogeny. Hum Mol Genet. 2020;29(5):766–84.
Cameron A, Erdogan M, Lanteigne S, Hetherington A, Inexperienced RS. Organ donation in trauma victims: a scientific evaluation and meta-analysis. J Trauma Acute Care Surg. 2018;84(6):994–1002.
Ma S, Zhu L, Fan X, Luo T, Liu D, Liang Z, et al. Melatonin derivatives fight with inflammation-related most cancers by focusing on the Important Perpetrator STAT3. Eur J Med Chem. 2021;211: 113027.
Klinges JG, Rosales SM, McMinds R, Shaver EC, Shantz AA, Peters EC, et al. Phylogenetic, genomic, and biogeographic characterization of a novel and ubiquitous marine invertebrate-associated Rickettsiales parasite, Candidatus Aquarickettsia rohweri, gen. nov., sp. nov. ISME J. 2019;13(12):2938–53.
Wang H, Lu L, Chen X, Bian Y, Ren ZJ. Geochemical and microbial characterizations of flowback and produced water in three shale oil and gasoline performs within the central and western United States. Water Res. 2019;164: 114942.
Corridor CS, Quirk JD, Goss CW, Lew D, Kozlowski J, Thomen RP, et al. Single-session bronchial thermoplasty guided by (129)Xe magnetic resonance imaging. A pilot randomized managed scientific trial. Am J Respir Crit Care Med. 2020;202(4):524–34.
Chang YH, Chu TY, Ding DC. Human fallopian tube epithelial cells exhibit stemness options, self-renewal capability, and Wnt-related organoid formation. J Biomed Sci. 2020;27(1):32.
Chang YH, Wu KC, Harnod T, Ding DC. Comparability of the fee and impact of mixed conditioned medium and standard medium for fallopian tube organoid cultures. Cell Transplant. 2023;32:9636897231160216.
Simintiras CA, Dhakal P, Ranjit C, Fitzgerald HC, Balboula AZ, Spencer TE. Seize and metabolomic evaluation of the human endometrial epithelial organoid secretome. Proc Natl Acad Sci USA. 2021;118(15):e2026804118.
Zhang H, Xu D, Li Y, Lan J, Zhu Y, Cao J, et al. Organoid transplantation can enhance reproductive prognosis by selling endometrial restore in mice. Int J Biol Sci. 2022;18(6):2627–38.
Hu B, Wang R, Wu D, Lengthy R, Fan J, Hu Z, et al. A promising new mannequin: institution of patient-derived organoid fashions overlaying HPV-related cervical pre-cancerous lesions and their cancers. Adv Sci (Weinh). 2024;11(12): e2302340.
